Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BLOC: Prospective Multi-Center Office Based Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception

NCT03433911 is registered in ClinicalTrials.gov with Femasys Inc. as lead sponsor.

NCT NCT03433911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BLOC: Prospective Multi-Center Office Based Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception
Lead sponsor
Femasys Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2018
Completion date
February 10, 2025
Enrollment
240 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

contraception